WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006114448) A CLOSED CONTAINER COMPRISING AN ACTIVATED FACTOR VII POLYPEPTIDE, PROCESSES FOR THE PREPARATION OF THE SAME, AND A KIT AND A METHOD FOR USE OF THE KIT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/114448    International Application No.:    PCT/EP2006/061921
Publication Date: 02.11.2006 International Filing Date: 28.04.2006
IPC:
A61K 9/00 (2006.01), A61K 9/08 (2006.01), A61K 38/37 (2006.01), A61K 38/48 (2006.01), C12N 9/64 (2006.01), A61P 7/04 (2006.01)
Applicants: NOVO NORDISK HEALTH CARE AG [CH/CH]; Andreasstrasse 15, CH-8050 Zurich (CH) (For All Designated States Except US).
ARENTSEN, Anne, Charlotte [DK/DK]; (DK) (For US Only).
KÆRSGAARD, Per [DK/DK]; (DK) (For US Only)
Inventors: ARENTSEN, Anne, Charlotte; (DK).
KÆRSGAARD, Per; (DK)
Common
Representative:
NOVO NORDISK A/S; Corporate Patents, Novo Allé, DK-2880 Bagsværd (DK)
Priority Data:
PA 2005 00619 28.04.2005 DK
Title (EN) A CLOSED CONTAINER COMPRISING AN ACTIVATED FACTOR VII POLYPEPTIDE, PROCESSES FOR THE PREPARATION OF THE SAME, AND A KIT AND A METHOD FOR USE OF THE KIT
(FR) CONTENANT FERME RENFERMANT UN POLYPEPTIDE DE FACTEUR VII ACTIVE, PROCESSUS DE PREPARATION DUDIT CONTENANT, KIT ASSOCIE, ET PROCEDE D'UTILISATION DUDIT KIT
Abstract: front page image
(EN)The present invention relates to a closed container holding a composition of an activated Factor VII polypeptide in an amount of in the range of 2.5-90 mg per imL volume of the container. The invention also relates to various processes for the preparation of such closed containers, a kit including such containers and a method of using the kit.
(FR)La présente invention concerne un contenant fermé renfermant une composition d'un polypeptide de facteur VII activé dans une quantité comprise entre 2,5 et 90 mg par mL du volume du contenant. Cette invention a aussi pour objet divers processus destinés à la préparation de tels contenants fermés, un kit comprenant ces contenants, et un procédé d'utilisation dudit kit.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)